SYRA vs. ELAB, IKT, ABVC, AIKI, GHSI, ERNA, MBRX, CHRO, COSM, and MNPR
Should you be buying Syra Health stock or one of its competitors? The main competitors of Syra Health include Elevai Labs (ELAB), Inhibikase Therapeutics (IKT), ABVC BioPharma (ABVC), AIkido Pharma (AIKI), Guardion Health Sciences (GHSI), Eterna Therapeutics (ERNA), Moleculin Biotech (MBRX), Chromocell Therapeutics (CHRO), Cosmos Health (COSM), and Monopar Therapeutics (MNPR). These companies are all part of the "medical" sector.
Syra Health (NASDAQ:SYRA) and Elevai Labs (NASDAQ:ELAB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.
Syra Health has higher revenue and earnings than Elevai Labs.
In the previous week, Syra Health had 2 more articles in the media than Elevai Labs. MarketBeat recorded 8 mentions for Syra Health and 6 mentions for Elevai Labs. Elevai Labs' average media sentiment score of 0.59 beat Syra Health's score of 0.41 indicating that Elevai Labs is being referred to more favorably in the news media.
Syra Health and Elevai Labs both received 0 outperform votes by MarketBeat users.
Syra Health has a net margin of 0.00% compared to Elevai Labs' net margin of -211.25%. Syra Health's return on equity of 0.00% beat Elevai Labs' return on equity.
4.8% of Syra Health shares are owned by institutional investors. Comparatively, 22.2% of Elevai Labs shares are owned by institutional investors. 10.2% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Syra Health beats Elevai Labs on 7 of the 10 factors compared between the two stocks.
Get Syra Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Syra Health Competitors List
Related Companies and Tools
